Clinical Trial Update: EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy - [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing EPA supplementation in cancer patients undergoing abdominal radiotherapy to address complications and nutritional concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Radiotherapy-related Complications

Snippet

Sponsor: Jens Rikardt Andersen | Conditions: Abdominal Cancer, Radiotherapy; Complications | Phase 4 | Status: UNKNOWN